Affiliation:
1. Institute of Basic Medical Sciences
2. Departments of Microbiology and Immunology
3. Department of Laboratory Medicine and Biotechnology
4. Institute of Medical Science, Medical College, Tzu Chi University, Hualien, Taiwan
5. Biochemistry
6. Pediatrics
7. Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng-Kung University, Tainan
Abstract
ABSTRACT
The oligopeptide permease (Opp) of group A streptococci (GAS) is a membrane-associated protein and belongs to the ATP-binding cassette transporter family. It is encoded by a polycistronic operon containing
oppA
,
oppB
,
oppC
,
oppD
, and
oppF
. The biological function of these genes in GAS is poorly understood. In order to understand more about the effects of Opp on GAS virulence factors, an
oppA
isogenic mutant was constructed by using an integrative plasmid to disrupt the
opp
operon and confirmed by Southern blot hybridization. No transcript was detected in the
oppA
isogenic mutant by Northern blot analysis and reverse transcriptase PCR. The growth curve for the
oppA
isogenic mutant was similar to that for wild-type strain A-20. The
oppA
isogenic mutant not only decreased the transcription of
speB
,
speX
, and
rofA
but also increased the transcription of
speF
,
sagA
(streptolysin S-associated gene A),
slo
(streptolysin O),
pel
(pleotrophic effect locus), and
dppA
(dipeptide permease). No effects on the transcription of
emm
,
sda
,
speJ
,
speG
,
rgg
, and
csrR
were found. The phenotypes of the
oppA
mutant were restored by the
oppA
revertant and by the complementation strain. The
oppA
mutant caused less mortality and tissue damage than the wild-type strain when inoculated into BALB/c mice via an air pouch. Based on these data, we suggest that the
opp
operon plays an important role in the pathogenesis of GAS infection.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference46 articles.
1. Alouf, J. E. 1980. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol. Ther.11:661-717.
2. Reduced Virulence of Group A Streptococcal Tn
916
Mutants That Do Not Produce Streptolysin S
3. Bisno, A. L., M. O. Brito, and C. M. Collins. 2003. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis.3:191-200.
4. Braun, M. A., D. Gerlach, U. F. Hartwig, J. H. Ozegowski, F. Romagne, S. Carrel, W. Kohler, and B. Fleischer. 1993. Stimulation of human T cells by streptococcal “superantigens” erythrogenic toxins (scarlet fever toxins). J. Immunol.150:2457-2466.
5. Caparon, M. G., and J. R. Scott. 1991. Genetic manipulation of pathogenic streptococci. Methods Enzymol.204:556-586.